Search

Your search keyword '"Lampasona V."' showing total 295 results

Search Constraints

Start Over You searched for: Author "Lampasona V." Remove constraint Author: "Lampasona V."
295 results on '"Lampasona V."'

Search Results

2. The immunological profile of SARS-CoV-2 infection in children is linked to clinical severity and age

3. Targeting CXCR1/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes

4. Targeting CXCR1/2 does not improve insulin secretion after pancreatic islet transplantation: A phase 3, double-blind, randomized, placebo-controlled trial in type 1 diabetes

5. Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19: Thromboembolism, diabetes and COVID-19

6. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

7. Autoantibodies neutralizing type I IFNs are present in similar to 4\% of uninfected individuals over 70 years old and account for similar to 20\% of COVID-19 deaths

8. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

11. Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2β) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials

14. Neuromyotonia in thymoma-associated myasthenia gravis: a clinico-serological study

15. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

16. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

17. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

19. Autoantibodies against zinc transporter 8 further stratify the autoantibody‐defined risk for type 1 diabetes in a general population of schoolchildren and have distinctive isoform binding patterns in different forms of autoimmune diabetes: results from the Karlsburg Type 1 Diabetes Risk Study

23. Acquired neuromyotonia in thymoma-associated myasthenia gravis: a clinical and serological study

27. Acquired neuromyotonia in thymoma‐associated myasthenia gravis: a clinical and serological study

29. Autoantibodies against zinc transporter 8 further stratify the autoantibody‐defined risk for type 1 diabetes in a general population of schoolchildren and have distinctive isoform binding patterns in different forms of autoimmune diabetes: results from the Karlsburg Type 1 Diabetes Risk Study

30. DROPLET DIGITAL PCR FOR DNMT3A AND IDH1/2 MUTATIONS TO IMPROVE EARLY DETECTION OF ACUTE MYELOID LEUKEMIA RELAPSE AFTER ALLOGENEIC HSCT

31. The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes

32. Droplet Digital PCR for DNMT3A and IDH1/2 Mutations to Improve Early Diagnosis of Acute Myeloid Leukemia Relapse after Allogeneic HSCT

34. Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2β) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials

36. Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome

38. Zinc Transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4

Catalog

Books, media, physical & digital resources